These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16248949)

  • 1. [Inhibition of mutant-type p53 by a chimeric U6 maxizyme in hepatocellular carcinoma cell lines].
    Kong XJ; Lin JS; Song YH; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):759-62. PubMed ID: 16248949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.
    Kong XJ; Song YH; Lin JS; Huang HJ; Wang NX; Liu NZ; Li B; Jin YX
    World J Gastroenterol; 2003 Jul; 9(7):1571-5. PubMed ID: 12854166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of mutant p53 in hepatocellular carcinoma cells by hammerhead ribozyme].
    Kong XJ; Lin JS; Song YH; Shen X; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):722-4. PubMed ID: 14697131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and localization of wild-type p53-GFP fused gene on human high-metastasis hepatocellular carcinoma cell line].
    He P; Tang Z; Ye S
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):105-7. PubMed ID: 10861118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity identification of anti-caspase-3 mRNA hammerhead ribozyme in both cell-free condition and BRL-3A cells.
    Xu R; Liu J; Zhou X; Xie Q; Jin Y; Yu H; Liao D
    Chin Med J (Engl); 2001 Jun; 114(6):606-11. PubMed ID: 11780436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Haas MJ; Pitot HC
    Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
    Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
    Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
    Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the cleavage activity of U1 small nuclear RNA chimeric ribozyme against HCV RNA in vitro].
    Tian MM; Wang F; Niu JQ; Wang MX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):749-51. PubMed ID: 15619345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF1A expression inhibits cell growth and enhances cell chemosensitivity to mitomycin in BEL-7402 hepatocellular carcinoma cells.
    Guan HG; Xue WJ; Qian HX; Zhou XJ; Qin L; Lan J
    Chin Med J (Engl); 2009 Jun; 122(11):1328-32. PubMed ID: 19567146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line.
    Chen XY; Li JS; Ma J; Duan FL; Zhong P
    Chin Med J (Engl); 2006 Oct; 119(20):1709-14. PubMed ID: 17097018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maxizyme technology.
    Iyo M; Kawasaki H; Taira K
    Methods Mol Biol; 2004; 252():257-65. PubMed ID: 15017055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.